Oxford’s COVID-19 vaccine may be mass produced in 2020
The vaccine produced an immune response in early-stage clinical trials with no major side effect.
The vaccine produced an immune response in early-stage clinical trials with no major side effect.
The human trials of the Oxford vaccine are expected to be through in September.